Massachusetts Financial Services
MYGN icon

Massachusetts Financial Services’s Myriad Genetics MYGN Stock Holding History

Massachusetts Financial Services’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$759K Sell
132,852
-5,294
-4% -$24K ﹤0.01% 912
2026
Q1 		$622K Buy
138,146
+20,710
+18% +$108K ﹤0.01% 880
2025
Q4 		$722K Buy
+117,436
New +$852K ﹤0.01% 850
2016
Q4 		– Sell
-21,524
Closed -$443K – 883
2016
Q3 		$443K Buy
21,524
+4,824
+29% +$122K ﹤0.01% 815
2016
Q2 		$511K Sell
16,700
-1,024
-6% -$35.6K ﹤0.01% 788
2016
Q1 		$663K Sell
17,724
-488
-3% -$18.4K ﹤0.01% 754
2015
Q4 		$786K Buy
+18,212
New +$769K ﹤0.01% 747
2013
Q4 		– Sell
-26,210
Closed -$616K – 846
2013
Q3 		$616K Sell
26,210
-960
-4% -$27.3K ﹤0.01% 775
2013
Q2 		$730K Buy
+27,170
New +$787K ﹤0.01% 750

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Massachusetts Financial Services's MYGN Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Myriad Genetics (MYGN) stake by 3.8% in Q2 2026, selling an estimated $24K and leaving 132,852 shares worth $759K. The position accounts for ﹤0.01% of the portfolio, ranked #912.

Massachusetts Financial Services first reported a position in MYGN in Q2 2013 and has held it in 9 quarters since. The position peaked at $786K in Q4 2015. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Massachusetts Financial Services held 132,852 shares of Myriad Genetics worth $759K as of Q2 2026.
  • Massachusetts Financial Services sold 5,294 Myriad Genetics shares in Q2 2026, an estimated $24K.
  • Myriad Genetics made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #912 holding.
  • Massachusetts Financial Services first reported a position in Myriad Genetics in Q2 2013 and has held it in 9 quarters since.
  • Massachusetts Financial Services's Myriad Genetics position peaked at $786K in Q4 2015.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.